AN2 Therapeutics (ANTX) PT Lowered to $2 at Evercore ISI
Tweet Send to a Friend
Evercore ISI analyst Liisa Bayko lowered the price target on AN2 Therapeutics (NASDAQ: ANTX) to $2.00 (from $7.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
